Paper52131
Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease.
Leibowitz M and 1 other. Neurology, 1975. Cited by 16 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone on the cardiovascular system of patients with parkinson's disease. Papers, record 52131. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/52131
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carbidopa | Major topic |
| Cardiovascular System | Major topic |
| Hydrazines | Major topic |
| Levodopa | Major topic |
| Parkinson Disease | Major topic |
| Adult | |
| Aged | |
| Arrhythmias, Cardiac | |
| Cardiac Complexes, Premature | |
| Clinical Trials as Topic | |
| Drug Combinations | |
| Female | |
| Humans | |
| Hypotension, Orthostatic | |
| Male | |
| Middle Aged | |
| Tachycardia |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28,679,598 | Mucuna pruriens in Parkinson disease: A double-blind, randomized, controlled, crossover study. | Neurology | 2017 | https://conductscience.org/library/papers/28679598 | PubMed |
| 23,772,219 | The management of orthostatic hypotension in Parkinson's disease. | Front Neurol | 2013 | https://conductscience.org/library/papers/23772219 | PubMed |
| 7,264,689 | Bromocriptine in Parkinson's disease: a study of cardiovascular effects. | J Neurol Neurosurg Psychiatry | 1981 | https://conductscience.org/library/papers/7264689 | PubMed |
| 6,435,991 | Anti-parkinsonian drugs today. | Drugs | 1984 | https://conductscience.org/library/papers/6435991 | PubMed |
| 2,202,385 | Determinants of gait in the elderly parkinsonian on maintenance levodopa/carbidopa therapy. | Br J Clin Pharmacol | 1990 | https://conductscience.org/library/papers/2202385 | PubMed |
| 797,502 | Clinical pharmacokinetics of levodopa in parkinson's disease. | Clin Pharmacokinet | 1976 | https://conductscience.org/library/papers/797502 | PubMed |
| 782,834 | Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. | Drugs | 1976 | https://conductscience.org/library/papers/782834 | PubMed |
| 731,241 | Effects of levodopa alone and in combination with dopa-decarboxylase inhibitors on plasma renin activity in patients with Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1978 | https://conductscience.org/library/papers/731241 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| DDC | 1,644 | PubTator's text mining | https://conductscience.org/library/genes/1644 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/52131
GET https://conductscience.org/api/papers/v1/52131/authors